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Ischemic mitral regurgitation (MR) is caused by altered left ventricular geometry and
function [1—3], doubling rates of heart failure and mortality after myocardial infarc-
tion [4]. Still common despite improvements in revascularization and medical treatments
after myocardial infarction, its treatment remains frustrating and controversial [5—10].
Restrictive annuloplasty, combined with coronary revascularization, is currently the most
commonly performed surgical procedure to treat chronic ischemic MR. However, the vari-
able results [6—8], potential for induction of mitral stenosis [9] and high rate of MR
recurrence after this strategy suggest the need for a new approach that addresses the
subvalvular mitral valve apparatus [11]. Thus, treatment beneﬁt remains hotly debated
and would be difﬁcult to resolve as long as existing therapies are incompletely effective in
permanently abolishing MR. New therapeutic opportunities are perplexing in their diver-
sity. By exploring such areas of confusion we will try to revisit fundamental principles and
achieve more effective solutions.
In ischemic MR, valve leaﬂets and chordae are structurally normal and MR results
from geometrical distortion of the subvalvular apparatus, secondary to left ventricular
enlargement and remodelling due to myocardial infarction. Burch et al. [12,13] postulated
restricted leaﬂet motion secondary to papillary muscle dysfunction. However, Tsakiris et al.
[14] have shown that papillary muscle dysfunction never produces MR. Moreover, Messas
et al. [15] demonstrated that papillary muscle dysfunction can paradoxically decrease
ischemic MR.
Thanks to the impressive work performed by Robert Levine (Massachusetts General
Hospital, Boston, MA, USA) over the past 10 years, we have an accurate understanding of
the characteristics of ischemic MR.
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Figure 1. Imbalance between tethering forces — annular dilata-
tion, left ventricular dilatation, papillary muscle displacement, left
ventricular sphericity — and closing forces, resulting in the reduc-
tion of coaptation surface and causing mitral regurgitation. Ao:
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oorta; LA: left atrium; PM: papillary muscle; MR: mitral regurgi-
ation.
The papillary muscles — normally located parallel to
he left ventricular long axis and perpendicular to the
eaﬂets — efﬁciently balance forces generated by ventri-
ular pressure on the leaﬂet surface. Ischemic or heart
ailure causes the myocardial segments underlying the pap-
llary muscles to bulge posteriorly and outward, displacing
he papillary muscles, so that they pull the leaﬂets non-
erpendicularly, away from their normal coaptation (Fig. 1).
he distance between the papillary muscle tips and the
nnulus also increases, drawing the leaﬂets into the left ven-
ricle and restricting their motion towards closure [16,17].
wo-dimensional echocardiography has demonstrated api-
ally restricted leaﬂet motion, called ‘incomplete mitral
eaﬂet closure’ [18,19]. The displacement of the leaﬂet
ttachments causes papillary muscle wall dysfunction or
[
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tethering’ of the papillary muscles. Inferior dyskinesis con-
ributes also to increased leaﬂet tethering [19].
Tethering is one facet of a unifying principle of mitral
alve function: leaﬂet motion is determined by the three-
imensional geometry of the leaﬂets and their attachments
elative to the surrounding ﬂow ﬁeld. Furthermore, ischemic
R reﬂects a basic imbalance between the size of the remod-
lling left ventricle and the mitral valve, which is tethered
y chordal connections to displaced papillary muscles and
annot close effectively. This dichotomy is a simpliﬁca-
ion. Recent works have determined whether and how the
itral valve adapts to such mechanical stresses and why
uch adaptation fails to prevent MR, and how we may aug-
ent leaﬂet area therapeutically. Clinical data from Chaput
t al. [20] indicate leaﬂet area averages 35% greater in
atients with left ventricular dysfunction compared with
ormal healthy controls, thus demonstrating that the mitral
alve undergoes adaptive and dynamic changes. Chaput
t al. [20] and Dal-Bianco et al. [22] have implemented
large-animal model for studying the effects of mechani-
al stretch on the mitral valve, independent of myocardial
nfarction and MR that may produce confounding effects.
he adaptation of the mitral valve using controlled tether-
ng stretch over 2months in the beating sheep heart without
yocardial infarction or MR, established under bypass, has
een performed in sheep. Stretch consistently increased
he leaﬂet area, measured over time by three-dimensional
cho, and augmented leaﬂet thickness by histopathology.
itral valve area increased by 17% over 2months with evi-
ence of a process of active cellular adaptation involving
ndothelial—mesenchymal transformation, beginning along
he atrial endothelium and penetrating into the valve inter-
titium. The potential mechanism for leaﬂet adaptation
nvolving increased leaﬂet length and interstitial thick-
ess includes the generation of transforming growth factor
eta by mechanically stretched valve interstitial cells and
yocytes [21], which induces endothelial—mesenchymal
ransformation in stretched excised mitral valves [22].
hese adaptive processes in the stretched mitral valve are
imilar to those involved in embryonic valve growth and
evelopment that can be reactivated in such conditions. The
till unmet question is why this adaptive mechanism does
ot fully compensate the leaﬂet tethering? Some paracrine
actors are likely to be involved and are the subject of inves-
igation.
Surgery for ischemic MR remains challenging. Standard
urgical therapy includes annular ring reduction, which aims
o improve leaﬂet apposition by correcting posterior annular
ilatation. Operative mortality is higher than in organic MR
nd the long-term prognosis is worse. Although often effec-
ive initially, long-term failures are increasingly recognized.
ndications for surgery and the preferred surgical procedure
n patients with ischemic MR remain controversial, mainly
ecause of the persistence and high recurrence rate of MR
fter mitral valve repair and the absence of evidence that
urgery prolongs life [7]. Experienced centres consistently
eport important persistent and recurrent MR, often months
fter surgery, in 30% or more of patients, casting doubt
n whether satisfactory early results represent success
7,9,23—25]. Severe ischemic MR is not usually improved by
evascularization alone, and the persistence of residual MR
arries an increased mortality risk. Several preoperative
185
Figure 2. Left panel: anterior leaﬂet bend by papillary muscle
displacement and leaﬂet tethering producing mitral regurgitation
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echocardiographic predictors of recurrent ischemic MR and
treatment failure, after undersized annuloplasty, have been
identiﬁed and are indicative of severe tethering, associated
with a poor prognosis. These include end-diastolic left
ventricular diameter > 65mm, mitral diastolic annulus
diameter≥ 37mm, posterior mitral leaﬂet angle > 45◦ (indi-
cating a high posterior leaﬂet restriction), distal anterior
mitral leaﬂet angle > 25◦, systolic tenting area > 2.5 cm2,
coaptation distance between the annular plane and the
coptation point > 10mm, end-systolic interpapillary muscle
distance > 20mm, and systolic sphericity index > 0.7 [26].
Intraoperative MR underestimation contributes to the
impression of recurrence but is only part of the problem. The
mitral valve is caught in a tug-of-war between the dilated
annulus and the displaced papillary muscles. Reducing annu-
lar size alone leaves persistent tethering to the displaced
left ventricular wall. Bach and Bolling [27] indicate that
ischemic MR is a ventricular — not a valvular — problem.
Calaﬁore et al. [23] have shown that annuloplasty failure
is predicted by greater preoperative leaﬂet tethering. Most
importantly, the ventricle is a moving target and often
continues to remodel and dilate, which renders initial repair
ineffective, as quantitatively conﬁrmed by Hung et al. [9].
Bach and Bolling introduced the most common, and increas-
ing, practice of implanting rings one or two sizes smaller
than predicted by measuring the ﬁbrous intertrigonal annu-
lus [27]. However, as mentioned by Tahta et al. [24], this
attempts to compensate for the fundamental problem, but
not correct it. McGee et al. [7] reported high-grade recur-
rent MR in 35% of patients 6months after surgery, highest
for pericardial annuloplasty but still 25% for Cosgrove and
complete Carpentier rings, with no signiﬁcant difference
between large and small rings. Rings also shift the poste-
rior annulus anteriorly, but the posterior leaﬂet remains
tethered posteriorly, so its anterior excursion is markedly
restricted; nearly rigid, it coapts poorly [9,28]. Modiﬁed
approaches include asymmetrical annuloplasty, ﬁrst intro-
duced by David [28], to reduce the largest leaﬂet gap,
located medially because the inferomedial papillary muscle
is most affected, bringing the vulnerable commissural
point closer to the papillary muscles to relieve tethering.
Furthermore, undersized annuloplasty does not improve
long-term survival in patients with chronic ischemic MR [5].
Such insights led to a novel surgical approach for chronic
ischemic MR. Subvalvular tethering can be relieved by mod-
ifying ventricular, leaﬂet or chordal structures (Fig. 2). An
alternative approach involves modifying the chordal tether-
ing mechanism directly, in ways suggested by valve anatomy
[17] and clinical observations [18,19,29]. Fine marginal
chordae position the leaﬂet tips and prevent prolapse:
thicker intermediate basal chordae insert closer to the
leaﬂet bases. With increased tethering, the basal anterior
leaﬂet near the annulus becomes nearly rigid and is tented
apically by these basal chordae. The more distal leaﬂet
pivots around the ‘knee’ where these chordae attach, but
only its tip can then approach the posterior leaﬂet, which
decreases the coaptational surface that normally seals the
oriﬁce. Messas et al. [30] therefore proposed that cutting a
limited number of these critically positioned basal chordae
can decrease ischemic MR: chordal cutting by eliminating
apical tenting, and relieving leaﬂet tethering, eliminates
the anterior leaﬂet bend and can make the leaﬂets less
i
a
t
dMR). Right panel: restoration of coaptation after basal chordal,
elieving tethering on the anterior leaﬂet.
aut, thus improving leaﬂet mobility and coaptation and
educing MR The intact marginal chordae continue to pre-
ent prolapse. These major series of large-animal models
xperiments on chordal cutting therapy to relieve mitral
alve tethering and ischemic MR showed incremental bene-
ts from chordal release without any adverse effects over
everal months on ventricular remodelling in a sheep model
f acute [30] and chronic [15,31] ischemic MR. As the leaﬂet
ethering is applied on both annular and papillary mus-
le levels, the same team used an experimental chronic
schemic MR sheep model to study the potential beneﬁt of
ssociating undersized ring annuloplasty with chordal cut-
ing. The association of both techniques improved results
ue to improved coaptation and reduced left ventricular
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emodelling with an incremental improvement over isolated
ndersized annuloplasty [11]. Clinical data from Borger
t al. [32] have shown that chordal cutting improves mitral
eaﬂet mobility and decreases MR recurrence in patients,
ithout any adverse effects on left ventricular function.
Finally, the tethering mechanism provides both annu-
ar and subvalvular targets for therapy, including reversing
eft ventricular geometric changes and leaﬂet or chordal
odiﬁcation. The likelihood of repair will be enhanced by
he availability of different options, obviating the need
or valve replacement. Detailed mapping of geometric sub-
trates should allow tailoring of the ideal combination of
nnular, ventricular and chordal approaches to achieve the
est result in each patient.
onclusion
nderstanding mechanisms of functional MR has led to
mproved therapies targeted to the primary causes. New
herapeutic options have the potential to provide a more
exible approach, adaptable to patients with diverse ven-
ricular and valvular changes. The guiding principle is to
chieve a comprehensive repair that addresses tethering at
oth ends of the leaﬂets. Leaﬂet tissue adaptation is also of
nterest and contributes to the mechanism of MR. Therefore,
n the near future, we expect that a combination of leaﬂet
issue biomechanic properties and three-dimensional sub-
alvular mitral valve apparatus analysis will help to resolve
his last frontier in valve disease.
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